Jason Hull, MD
Adult Reconstructive Orthopaedic Surgery · Richmond, VANPI 1083707905
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $52,538 of the $65,618 with a category attached, or 80.1%. Encore Medical, LP accounts for 99.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $28,205 and has fallen 93.5% since, to $1,845 in 2025.
Across 102 payments — averaging $643.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$65K
- Zimmer Biomet$323
- Johnson & Johnson$56
- Stryker$44
- Insight Medical Systems, Inc.$41
- Davol Inc.$24
- plus $64 from 3 others
What the payments were for
- Consulting fees$52,53880%
- Speaking & faculty fees$1,5002%
- Travel & lodging$8,50113%
- Food & beverage$3,0795%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 89 | $65,066 |
| Zimmer Biomet | 4 | $323 |
| Johnson & Johnson | 3 | $56 |
| Stryker | 1 | $44 |
| Insight Medical Systems, Inc. | 1 | $41 |
| Davol Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Fortis Surgical, LLC | 1 | $21 |
| Smith+Nephew | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,618 in reported general payments places this provider in the 80th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.
See all adult reconstructive orthopaedic surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 134 | $1,786 |
| Diclofenac Sodium | 60 | $772 |
| Cephalexin | 220 | $320 |
| Methylprednisolone | 27 | $201 |
| Oxycodone Hcl | 11 | $55 |
| Clindamycin Hcl | 18 | $26 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Richmond
- John CardeaRichmond$141K
- Matthew DobzyniakRichmond$41K
- Chijindu EmenariRichmond$11K
- Robert AdelaarRichmond$1K
- Ruben MonarrezRichmond$194
- Nikhil AilaneyRichmond$152
- Nitin GoyalArlington$81.5M
- William HamiltonAlexandria$9.3M
- Charles EnghArlington$5.5M
- James BrowneCharlottesville$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.